Bixiye
QP10-19 Pharmacy Benefit Exclusion for Dymista, Duexis, Qbrexza, Vimovo, and Yosprala
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2671 - 2680 ee natiijooyinka 3167
Bixiye
QP14-19 Minnesota Health Care Programs (MHCP) Claims Pending
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP8-19 Addition of Drugs to the Oral Tetracycline Derivatives Prior Authorization Program
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP12-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization Criteria: Immune Globulins
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP15-19 Online Medical Policy Surveys for Authorizations
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP9-19 Addition of Drugs to existing Prior Authorization with Quantity Limit Programs
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
P21-19 Reminder Regarding Minnesota Health Care Programs and Minnesota Senior Health Options Pre-certification Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Jan 31, 2019
Bixiye
P14-19 Reminder: Change to TPA Business
Taariikhda uu dhaqangalayo Barnaamijka: Jan 30, 2019
Bixiye
P16-19 New Medical Drug-Related Prior Authorization Requirements for Zolgensma
Taariikhda uu dhaqangalayo Barnaamijka: Jan 30, 2019
Bixiye
P17-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Medicare Advantage Lines of Business - Effective April 8, 2019
Taariikhda uu dhaqangalayo Barnaamijka: Jan 30, 2019